Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer
PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
February 1, 2002
Primary Completion Date
August 10, 2004
Study Completion Date
July 31, 2006
Conditions
Prostate Cancer
Interventions
BIOLOGICAL
Dendritic Cells (DC) prostate
Trial Locations (1)
Unknown
Oslo university Hospital, Oslo
All Listed Sponsors
lead
Oslo University Hospital
OTHER
NCT01278914 - Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter